ReviewHeart failure reviews2025

The impact of oral semaglutide on cardiovascular events in patients with type 2 diabetes: review of results from the SOUL trial.

Katy S Lehenbauer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.